Por: Forbes Tech January 19, 2023
A gymnast grabs two rings - one in each hand.univsport.com The current generation of monoclonal antibodies is ineffective against the predominant variants of SARS-CoV-2 in circulation. Recent studies by Callaway et al. open the possibility that a new type of monoclonal antibody may regain some of the lost activity. These are bivalent antibodies that recognize two sites on the virus simultaneously. From the early days of the pandemic, the... + full article
Time USA Health January 27, 2023
In a unanimous decision, all 21 voting members of the U.S. Food and Drug Administration’s (FDA) vaccine committee recommended that the U.S. start using the same COVID-19 virus strain in all of the COVID-19 vaccines, including primary and booster doses. That means the bivalent... + más
Kids 5-11 can now get the bivalent, BA.5-targeting COVID booster | Ars Technica
FDA greenlights bivalent vaccines for children as young as 6 months old | Politico
Time USA Health January 26, 2023
The Omicron variant has morphed into more than half a dozen different strains—the latest of which include BQ.1.1 and XBB.1, and XBB.1.5. Combined, these variants and their close relatives now account for nearly in the U.S. But so far, no COVID-19 vaccine directly targets them.... + más
Here’s Why Experts Believe the New Omicron Booster Will Work | Time
First Real-World Data Show That the Bivalent Booster Is Effective | Time
Time USA Health December 13, 2022
When SARS-CoV-2 was a brand-new virus, it met little resistance in immune-naïve hosts—that is, us. Vaccines, boosters, and infections have increased our immunity to varying degrees. But how much protection do each of these provide at this point in the pandemic? Here’s what... + más
Democratic Rep. Dingell stunned as Biden floats immunity for Saudi prince | Newsweek
Shaikin: Baseball embracing the 'flukes' and plenty of added revenue this postseason | Los Angeles Times
Politico USA Health December 08, 2022
The FDA on Thursday authorized emergency use of updated bivalent Covid-19 vaccines for children as young as 6 months old. The move to authorize bivalent shots made by Pfizer-BioNTech and Moderna comes as Covid-19 infections in the United States tick up amid the most intense flu... + más
FDA authorizes bivalent COVID-19 boosters for children as young as 6 months | WGN-TV
ABC7 USA Health November 14, 2022
Moderna said on Monday its updated Covid-19 booster generated significantly higher neutralizing antibodies against the Omicron BA.4/BA.5 subvariants than its earlier shot.The bivalent booster used in the United States is known as mRNA-1273.222; it contains Moderna's... + más
Moderna says new Covid booster better against omicron BA.5, triggers immune response against BQ.1.1 | CNBC
Moderna vs Pfizer: Is it OK to mix and match the updated COVID-19 booster shots? | Los Angeles Times
Time USA Health November 14, 2022
In a news published Nov. 14, Moderna said its updated Omicron booster shot targeting the variants BA.4 and BA.5 produced higher levels of antibodies against those versions of the virus than its original shot did. Compared to Moderna’s original booster, the Omicron booster... + más
Moderna Stock Futures: Is COVID Vaccine Maker Moderna Poised To Pop Or Drop? | Forbes
Time USA Health September 24, 2022
A published Sept. 16 in the New England Journal of Medicine (NEJM) makes a strong case for an Omicron-based COVID-19 booster shot. But first, a caveat: There are no data available yet demonstrating the effectiveness of the new Omicron booster on Aug. 31, which protects against... + más
Moderna-backed mouse study offers first head-to-head BA.5, BA.1 booster data | Ars Technica
Here’s How Effective the Original Vaccines Are Against Omicron | Time
About iurex | Privacy Policy | Disclaimer |